1200 related articles for article (PubMed ID: 19388925)
21. [Thrombophilia and pregnancy].
Carlizza A
Minerva Cardioangiol; 2006 Dec; 54(6):799-801. PubMed ID: 17393610
[TBL] [Abstract][Full Text] [Related]
22. Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery Study.
Kahn SR; Springmann V; Schulman S; Martineau J; Stewart JA; Komari N; McLeod A; Strulovitch C; Blostein M; Faucher JP; Gamble G; Gordon W; Kagoma PK; Miron MJ; Laverdière D; Game M; Mills A
Thromb Haemost; 2012 Sep; 108(3):493-8. PubMed ID: 22782073
[TBL] [Abstract][Full Text] [Related]
23. The risk of recurrent venous thromboembolism in pregnancy and puerperium without antithrombotic prophylaxis.
De Stefano V; Martinelli I; Rossi E; Battaglioli T; Za T; Mannuccio Mannucci P; Leone G
Br J Haematol; 2006 Nov; 135(3):386-91. PubMed ID: 16984390
[TBL] [Abstract][Full Text] [Related]
24. Safety of withholding heparin in pregnant women with a history of venous thromboembolism. Recurrence of Clot in This Pregnancy Study Group.
Brill-Edwards P; Ginsberg JS; Gent M; Hirsh J; Burrows R; Kearon C; Geerts W; Kovacs M; Weitz JI; Robinson KS; Whittom R; Couture G;
N Engl J Med; 2000 Nov; 343(20):1439-44. PubMed ID: 11078768
[TBL] [Abstract][Full Text] [Related]
25. The effect of dalteparin on coagulation activation during pregnancy in women with thrombophilia. A randomized trial.
Abou-Nassar K; Kovacs MJ; Kahn SR; Wells P; Doucette S; Ramsay T; Clement AM; Khurana R; Mackinnon K; Blostein M; Solymoss S; Kingdom J; Sermer M; Rey E; Rodger M;
Thromb Haemost; 2007 Jul; 98(1):163-71. PubMed ID: 17598009
[TBL] [Abstract][Full Text] [Related]
26. Thromboprophylaxis with low-molecular-weight heparin after cesarean delivery.
Blondon M; Perrier A; Nendaz M; Righini M; Boehlen F; Boulvain M; De Moerloose P
Thromb Haemost; 2010 Jan; 103(1):129-37. PubMed ID: 20062923
[TBL] [Abstract][Full Text] [Related]
27. Risk stratification and heparin prophylaxis to prevent venous thromboembolism in pregnant women.
Bauersachs RM; Dudenhausen J; Faridi A; Fischer T; Fung S; Geisen U; Harenberg J; Herchenhan E; Keller F; Kemkes-Matthes B; Schinzel H; Spannagl M; Thaler CJ;
Thromb Haemost; 2007 Dec; 98(6):1237-45. PubMed ID: 18064320
[TBL] [Abstract][Full Text] [Related]
28. Cost-effectiveness of prophylactic low molecular weight heparin in pregnant women with a prior history of venous thromboembolism.
Johnston JA; Brill-Edwards P; Ginsberg JS; Pauker SG; Eckman MH
Am J Med; 2005 May; 118(5):503-14. PubMed ID: 15866253
[TBL] [Abstract][Full Text] [Related]
29. The management of thrombosis in pregnancy: role of low-molecular-weight heparin.
Kher A; Bauersachs R; Nielsen JD
Thromb Haemost; 2007 Apr; 97(4):505-13. PubMed ID: 17393011
[TBL] [Abstract][Full Text] [Related]
30. [Pregnancy-associated venous thrombosis in women with hereditary heterozygous factor V Leiden and/or factor II gene mutations].
Samama MM; Rached RA; Conard J; Horellou MH; Elalamy I
Bull Acad Natl Med; 2004; 188(8):1377-93; discussion 1393-6. PubMed ID: 15918665
[TBL] [Abstract][Full Text] [Related]
31. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
Cohen AT; Nandini B; Wills JO; Ota S
Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
[TBL] [Abstract][Full Text] [Related]
32. Venous thromboembolism in patients with advanced cancer under palliative care: additional risk factors, primary/secondary prophylaxis and complications observed under normal clinical practice.
Soto-Cárdenas MJ; Pelayo-García G; Rodríguez-Camacho A; Segura-Fernández E; Mogollo-Galván A; Giron-Gonzalez JA
Palliat Med; 2008 Dec; 22(8):965-8. PubMed ID: 18952751
[TBL] [Abstract][Full Text] [Related]
33. [Prophylaxis of recurrence during transient risk in patients with previous venous thromboembolism].
Schmidt B; Schellong S
Med Klin (Munich); 2003 Aug; 98(8):447-52. PubMed ID: 12928810
[TBL] [Abstract][Full Text] [Related]
34. Diagnosis, treatment, and prevention of venous thromboembolism in pregnancy.
Marshall AL
Postgrad Med; 2014 Nov; 126(7):25-34. PubMed ID: 25387211
[TBL] [Abstract][Full Text] [Related]
35. Pregnancy-Related Venous Thromboembolism.
Armstrong EM; Bellone JM; Hornsby LB; Treadway S; Phillippe HM
J Pharm Pract; 2014 Jun; 27(3):243-52. PubMed ID: 24742932
[TBL] [Abstract][Full Text] [Related]
36. Pregnancy-related venous thromboembolism: risk and the effect of thromboprophylaxis.
Lussana F; Coppens M; Cattaneo M; Middeldorp S
Thromb Res; 2012 Jun; 129(6):673-80. PubMed ID: 22365492
[TBL] [Abstract][Full Text] [Related]
37. Use of low-molecular-weight heparin from the first trimester of pregnancy: a retrospective study of 111 consecutive pregnancies.
Deruelle P; Denervaud M; Hachulla E; Ducloy-Bouthors AS; Valat AS; Puech F; Trillot N; Hatron PY; Subtil D
Eur J Obstet Gynecol Reprod Biol; 2006 Jul; 127(1):73-8. PubMed ID: 16242833
[TBL] [Abstract][Full Text] [Related]
38. Exploring the role of low-molecular-weight heparins in pregnancy.
Greer IA
Semin Thromb Hemost; 2002 Aug; 28 Suppl 3():25-31. PubMed ID: 12232820
[TBL] [Abstract][Full Text] [Related]
39. Prophylaxis and treatment of thrombophilia in pregnancy.
Gris JC; Lissalde-Lavigne G; Quéré I; Dauzat M; Marès P
Curr Opin Hematol; 2006 Sep; 13(5):376-81. PubMed ID: 16888444
[TBL] [Abstract][Full Text] [Related]
40. Fondaparinux for prevention of venous thromboembolism in high-risk trauma patients: a pilot study.
Lu JP; Knudson MM; Bir N; Kallet R; Atkinson K
J Am Coll Surg; 2009 Nov; 209(5):589-94. PubMed ID: 19854398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
